We are live on ! Find out more
VCM

Vigilant Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+15.33%
3 Year Est. Return
+48.75%
5 Year Est. Return
+353.4%
10 Year Est. Return
+645.13%
AUM
$1.12B
AUM Growth
+$80.5M
Cap. Flow
+$43.6M
Cap. Flow %
3.88%
Top 10 Hldgs %
30.33%
Holding
395
New
66
Increased
74
Reduced
103
Closed
39

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$18.1M
2
GS icon
Goldman Sachs
GS
+$15.5M
3
TXG icon
10x Genomics
TXG
+$9.95M
4
V icon
Visa
V
+$2.59M
5
ABT icon
Abbott
ABT
+$2.3M

Sector Composition

Rank Sector Weight
1 Technology 20.2%
2 Healthcare 15.54%
3 Financials 11.49%
4 Consumer Discretionary 10.49%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TD icon
376
Toronto Dominion Bank
TD
$200B
-50
Closed -$3K
TIP icon
377
iShares TIPS Bond ETF
TIP
$14.7B
-896
Closed -$114K
TSCO icon
378
Tractor Supply
TSCO
$18B
-2,430
Closed -$68K
XLP icon
379
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
-534
Closed -$36K
XMLV icon
380
Invesco S&P MidCap Low Volatility ETF
XMLV
$741M
-5,087
Closed -$245K
YUMC icon
381
Yum China
YUMC
$16.5B
-760
Closed -$43K
CFMS
382
DELISTED
Conformis, Inc. Common Stock
CFMS
-240
Closed -$4K
INFO
383
DELISTED
IHS Markit Ltd. Common Shares
INFO
-148
Closed -$13K
BMY.RT
384
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-2,503
Closed -$2K

Similar funds

Vigilant Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Vigilant Capital Management held 395 positions worth $1.12B, up 7.7% from $1.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Vigilant Capital Management deployed $43.6M of net new capital in Q1 2021, opening 66 new positions and adding to 74 existing holdings. Its largest new stake was 10x Genomics: 57,590 shares worth $10.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $8.4M trimmed.

  • Vigilant Capital Management's largest Q1 2021 buy was 10x Genomics: 57,590 shares worth $10.4M.
  • Vigilant Capital Management added most to Ecolab in Q1 2021, an estimated $18.1M increase.
  • Vigilant Capital Management's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $8.4M.
  • Vigilant Capital Management fully exited iShares Core Universal USD Bond ETF in Q1 2021, selling an estimated $682K.
  • Vigilant Capital Management's ten largest holdings make up 30% of its $1.12B portfolio in Q1 2021.
  • Vigilant Capital Management opened 66 new positions and closed 39 in Q1 2021.
  • Vigilant Capital Management's portfolio value rose 7.7% quarter-over-quarter to $1.12B.

Based on Vigilant Capital Management's 13F filing for Q1 2021, filed 16 Apr 2021.